Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status

Clinical and Vaccine Immunology

Volumn 19, Issue 2, 2012, Pages 198-208

  Yu, Xian ^a   Prados Rosales, Rafael ^a   Jenny Avital, Elisabeth R ^a   Sosa, Katherine ^a   Casadevall, Arturo ^a   Achkar, Jacqueline M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOMANNAN; BACTERIAL PROTEIN; GLUCAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; LIPOARABINOMANNAN; MALATE SYNTHASE; PROTEIN MPT51; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL MEMBRANE; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SPUTUM SMEAR; STRAIN DIFFERENCE; TUBERCULOSIS;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; FEMALE; GLUCANS; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALATE SYNTHASE; MALE; MANNANS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SEROLOGIC TESTS; TUBERCULOSIS;

EID: 84856460004     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05550-11     Document Type: Article

References (51)

1. Achkar JM, Jenny-Avital E. 2011. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J. Infect. Dis. 204:S1179-S1186.
2. Achkar JM, et al. 2010. Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status. Clin. Vaccine Immunol. 17:384-392.
3. Brown RM, et al. 2003. Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette- Guerin vaccination. J. Infect. Dis. 187:513-517. (Pubitemid 36184595)
4. Chatterjee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ. 1992. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 267:6234-6239.
5. Coates SR, et al. 1986. Identification of Mycobacterium tuberculosis antigens in Seibert fractions by immunoblotting. J. Clin. Microbiol. 24:126-130. (Pubitemid 16090250)
6. Condos R, Rom WN, Liu YM, Schluger NW. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. Am. J. Respir. Crit. Care Med. 157:729-735.
7. Da Costa CT, Khanolkar-Young S, Elliott AM, Wasunna KM, McAdam KP. 1993. Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin. Exp. Immunol. 91:25-29. (Pubitemid 23027992)
8. Daffé M, Etienne G. 1999. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber. Lung Dis. 79:153-169. (Pubitemid 29348506)
9. Davidow A, et al. 2005. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect. Immun. 73:6846-6851. (Pubitemid 41368852)
10. - individuals. Clin. Exp. Immunol. 99:425- 432.
11. Dhandayuthapani S, Izumi S, Anandan D, Bhatia VN. 1992. Specificity of IgG subclass antibodies in different clinical manifestations of leprosy. Clin. Exp. Immunol. 88:253-257.
12. Dinadayala P, Sambou T, Daffé M, Lemassu A. 2008. Comparative structural analyses of the alpha-glucan and glycogen from Mycobacterium bovis. Glycobiology 18:502-508. (Pubitemid 351865830)
13. Gagliardi MC, et al. 2007. Cell wall-associated alpha-glucan is instrumental for Mycobacterium tuberculosis to block CD1 molecule expression and disable the function of dendritic cell derived from infected monocyte. Cell. Microbiol. 9:2081-2092. (Pubitemid 47087097)
14. Glatman-Freedman A. 2006. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy. Tuberculosis (Edinb.) 86:191-197.
15. Glatman-Freedman A, et al. 2004. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. J. Clin. Microbiol. 42:3225-3231. (Pubitemid 38938084)
16. Gounder C, et al. 2002. Field evaluation of a rapid immunochromatographic test for tuberculosis. J. Clin. Microbiol. 40:1989-1993. (Pubitemid 34596373)
17. Guerardel Y, et al. 2002. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with α1,3-mannopyranose side chains. J. Biol. Chem. 277:30635-30648. (Pubitemid 34970759)
18. Hamasur B, et al. 2003. Mycobacterium tuberculosis arabinomannanprotein conjugates protect against tuberculosis. Vaccine 21:4081-4093. (Pubitemid 37338234)
19. Kekow J, Hobusch G, Gross WL. 1988. Predominance of the IgG1 subclass in the hypergammaglobulinemia observed in pre-AIDS and AIDS. Cancer Detect. Prev. 12:211-216.
20. Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D. 1995. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 270:12380-12389.
21. Kunnath-Velayudhan S, et al. 2010. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl. Acad. Sci. U. S. A. 107:14703-14708.
22. Lane HC, et al. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453- 458.
23. Lemassu A, Daffé M. 1994. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem. J. 297(Pt 2):351-357. (Pubitemid 24026429)
24. Lyashchenko K, et al. 1998. Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66:3936-3940. (Pubitemid 28347858)
25. McEllistrem MC. 2009. Genetic diversity of the pneumococcal capsule: implications for molecular-based serotyping. Future Microbiol. 4:857-865.
26. Morris K. 2011. WHO recommends against inaccurate tuberculosis tests. Lancet 377:113-114.
27. Navoa JA, et al. 2003. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clin. Diagn. Lab. Immunol. 10:88-94. (Pubitemid 36133835)
28. O'Riordan K, Lee JC. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17:218-234. (Pubitemid 38120935)
29. Parra M, et al. 2009. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin. Vaccine Immunol. 16:1025-1032.
30. Prados-Rosales R, et al. 2011. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J. Clin. Invest. 121:1471-1483.
31. Riesen WF, Skvaril F, Braun DG. 1976. Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies. Scand. J. Immunol. 5:383-390.
32. Sahiratmadja E, et al. 2007. Dynamic changes in pro- and antiinflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829. (Pubitemid 46203445)
33. Samanich K, Belisle JT, Laal S. 2001. Homogeneity of antibody responses in tuberculosis patients. Infect. Immun. 69:4600-4609. (Pubitemid 32574461)
34. Samanich KM, et al. 1998. Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J. Infect. Dis. 178:1534-1538.
35. Samanich KM, et al. 2000. Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 7:662-668. (Pubitemid 30463230)
36. Sani M, et al. 2010. Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog. 6:e1000794.
37. Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT. 2006. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol. Cell. Proteomics 5:2102-2113. (Pubitemid 44817022)
38. Schwebach JR. 2002. The carbohydrate surface of M. tuberculosis: antigenicity and antibody immunity. Ph.D. thesis. Albert Einstein College of Medicine, Bronx, New York.
39. Schwebach JR, et al. 2001. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect. Immun. 69:5671-5678. (Pubitemid 32786505)
40. Schwebach JR, et al. 2002. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo. Infect. Immun. 70:2566-2575. (Pubitemid 34408401)
41. Siber GR, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. 1980. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 303:178-182. (Pubitemid 10004258)
42. Siev M, et al. 2011. Correlation between serum and plasma antibody titers to mycobacterial antigens. Clin. Vaccine Immunol. 18:173-175.
43. Skvaril F. 1986. IgG subclasses in viral infections. Monogr. Allergy 19: 134-143.
44. Steingart KR, et al. 2009. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 16:260-276.
45. Steingart KR, et al. 2007. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 4:e202.
46. Steingart KR, et al. 2007. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Postgrad. Med. J. 83:705-712. (Pubitemid 350207516)
47. Stokes RW, et al. 2004. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect. Immun. 72:5676-5686. (Pubitemid 39303677)
48. Taborda CP, Casadevall A. 2001. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J. Immunol. 166:2100-2107. (Pubitemid 32114700)
49. Tessema TA, et al. 2002. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary antilipoarabinomannan detection in pulmonary tuberculosis. Scand. J. Infect. Dis. 34:97-103. (Pubitemid 34213369)
50. Wanchu A, et al. 2008. Biomarkers for clinical and incipient tuberculosis: performance in a TB-endemic country. PLoS One 3:e2071.
51. World Health Organization. 2008. Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland.